JFL LIFE Sciences Limited

Jfl Life Sciences Limited (JFLLIFE) is a micro-cap Healthcare company valued at ₹36 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Jfl Life Sciences Limited last traded at ₹10.35, down 4.61% on the day.

Financial performance

The company's business has grown significantly, with annual revenue rising 60.2% and net profit increasing 60.0% year-over-year. However, the latest quarter showed a decline in revenue compared to the same quarter a year earlier, while net profit rose sharply.

Valuation multiples

The stock trades at 5.3 times earnings, a discount to the Healthcare median of 32.0, 0.77 times book value. It yields 2.4%.

Things to watch

The stock is 35.1% below its 52-week high, indicating a recent pullback. The net profit margin remained flat at 4.9%, despite rising revenue, which could signal pressure on pricing power or cost management.

Where it stands

JFL Life Sciences Ltd has delivered strong growth in both revenue and net profit over the past year and five years, but the latest quarter shows a reversal in revenue trends. The stock is trading below its recent high, and the net profit margin has not improved despite higher sales.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.